Now live LuminLogic® NextGen is here. The AI-enabled eQMS & regulatory compliance platform. Explore NextGen

From Clearance to Commercialization, With Confidence

Meet with MethodSense at AMDS

Compliance after clearance is complex. MethodSense combines consulting and LuminLogic to give medtech innovators scalable, investor-trusted compliance systems, and give strategics confidence in every deal.

The Hidden Risk After Clearance

Why Compliance Can’t Be an Afterthought

The risks don’t stop after clearance. Missed obligations, poor documentation, or weak systems can derail growth or tank a deal.

  • Missed deadlines or weak documentation trigger fines, audits, or lost trust
  • Growth firms underestimate postmarket obligations until costs surge
  • Strategics risk acquisitions if regulatory gaps go unchecked
Compliance Without the Burden

The Smarter Way to Scale

MethodSense delivers a co-managed model, regulatory expertise paired with LuminLogic’s powerful compliance platform.

  • Complaint intake, submissions, CAPA, and audits simplified and integrated
  • MDR reporting workflows aligned with FDA and EU MDR
  • Scalable systems that evolve as companies grow or globalize
  • Regulatory insight that supports acquisition diligence and integration
Trusted by Startups and Strategics

25+ Years of Regulatory Wins

For 25 years, MethodSense has been the trusted partner guiding medtech innovators and strategics alike.

  • 200+ FDA wins across diverse device categories
  • Consultants + SaaS integration provide unique speed and clarity
  • Trusted by investors, startups, and Fortune 500 strategics
  • Proven ability to solve known problems and anticipate emerging ones
Designed for Innovators & Acquirers

Value for Growth Firms, Strategics, Investors

MethodSense services and LuminLogic platform deliver measurable value for innovators, acquirers, and executive leadership teams.

  • QA/RA Leaders: Audit-ready documentation and streamlined workflows
  • Executives/CEOs: Risk reduction, capital preservation, investor confidence
  • Strategics/Investors: Deal flow confidence and post-acquisition integration support

Let’s Get Started at AMDS

It’s your growth engine. With MethodSense, you can safeguard patients, protect investors, and scale faster with confidence.

Build investor-trusted compliance systems that accelerate funding or exit. Ensure scalable, audit-ready processes to support rapid growth. Gain clarity and control without overextending internal resources

Email UsCall UsContact Form
Send us your compliance questionsSpeak directly with our regulatory teamSchedule a meeting
Send an Email+1 (919) 313-3960Fill Out the Form

What MedTech Innovators Say About MethodSense

Rhythmedix

Working with MethodSense was the best decision we could have made. Their regulatory expertise and understanding of our product helped us navigate a complex situation with the FDA. Their guidance not only ensured compliance but bolstered investor confidence.

Brian Pike
Brian Pike
Co-Founder & President, Rhythmedix
OxiWear

For a startup navigating the FDA for the first time, LuminLogic wasn’t just software. It was our second brain. It gave our whole team immediate access to the regulatory knowledge we needed, made complex processes understandable, streamlined document management, and kept everyone aligned without constant back-and-forth. It allowed us to work smarter and faster toward compliance and launch.

Shavini Fernando
Shavini Fernando
Founder & CEO, OxiWear
Seneca Devices, Inc.

LuminLogic is more than a compliance tool. It’s a system that brings structure and organization to how we run our entire company. It enables us to manage everything from engineering and design records to complaint handling and CAPAs, all in one validated, secure platform.

Sam Fox
Sam Fox
CEO, Seneca Devices, Inc.